🔎 Trials Near Me

Akèy › Maladi selil fòs › Maryland › Baltimore

Etid klinik pou Maladi selil fòs nan Baltimore, MD

7 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

Ap rekriteFaz 3
  • The Johns Hopkins University School of Medicine, Baltimore
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Local Institution - 0064, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Ap rekriteEtid obsèvasyon
  • Johns Hopkins University Hemophilia Treatment Center, Baltimore
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

Ap rekriteFaz 2
  • University of Maryland, Baltimore
Laj 12 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT06699849

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Ap rekriteFaz 3
  • University of Maryland School of Medicine - Baltimore- Site Number : 8400041, Baltimore
Laj 10 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT06975865

Cooperative Assessment of Late Effects for SCD Curative Therapies

Ap rekriteEtid obsèvasyon
  • Johns Hopkins Hospital, Baltimore
Laj 4 a 65 · Tout sèks · Mizajou Jul 27, 2026 · NCT05153967

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Ap rekrite
  • University of Maryland Medical Systems, Baltimore
Laj 18 ak plis · Tout sèks · Mizajou Dec 24, 2025 · NCT06184126

Etid Maladi selil fòs nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.